EUVIMEDEUVIMED entdecken
Fallbericht

Isolation of OXA-48-like carbapenemase-producing Escherichia coli susceptible to piperacillin/tazobactam in a Japanese patient without a history of travel abroad

Masahiko Kaneko, Yuya Masuda, Hiroshi Sawachika, Hisaharu Shikata, Chie Moriyama, Minako Miura, Hisato Yamamoto, Taro Nakamura, Komami Fukumoto, Yasushi Utsunomiya, Kyoko Sakai, Yuri Ito und 3 weitere

Journal of Infection and Chemotherapy · 2023

DOI: 10.1016/j.jiac.2023.01.024 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Infection and Chemotherapy, 2023. Verfasst von Masahiko Kaneko und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Uwajima City Hospital, Ehime, 798-8510, Japan. Electronic address: kaneko@uwajima-mh.jp. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Carbapenem-Resistant Enterobacteriaceae. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxacillinase (OXA)-48-like β-lactamases are the most common carbapenemases in Enterobacterales in certain regions of the world and are being introduced on a regular basis into regions of non-endemicity. Japan has been characterized by low rates of carbapenemase-producing Enterobacterales, and among them, OXA-48-like carbapenemase-producing isolates are extremely rare. Here we describe a Japanese medical worker, without a history of travel abroad, who was diagnosed as having a community-acquired urinary tract infection, and whose urine sample was found to be positive for OXA-48-like carbapenemase-producing Escherichia coli. None of her close contacts had a history of foreign travel, and the same drug-resistant organism was not observed in other patients who had been hospitalized and undergone environmental culture tests in the same medical institution. This isolate was resistant to penicillins, narrow-spectrum cephalosporins, fluoroquinolones, and cefmetazole, but was susceptible to broad-spectrum cephalosporins, piperacillin/tazobactam, and meropenem and displayed reduced susceptibility to imipenem. The modified carbapenem inactivation test supported carbapenemase production, but inhibitor-based synergistic tests yielded negative results of carbapenemase production. Multiplex polymerase chain reaction revealed the presence of the carbapenemase gene (blaOXA-48) blaTEM and AmpC β-lactamase gene (blaDHA). Singleplex polymerase chain reaction targeting the blaOXA-48 region amplified a product sequencing to nearly the full length (722 bp) and matching 100% with OXA-48. The present case highlights a new concern regarding OXA-48-like carbapenemase-producing Enterobacterales, which remain challenging to detect for clinical laboratories in regions of non-endemicity, and may already be latent in Japan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsCarbapenem-Resistant EnterobacteriaceaeHumansFemaleEast Asian PeopleBacterial Proteinsbeta-LactamasesEscherichia coliPiperacillin, Tazobactam Drug CombinationCephalosporinsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Carbapenemase-producing enterobacteralesEscherichia coliOXA-48-like carbapenemasePiperacillin/tazobactam

Substanzen

carbapenemaseoxacillinaseAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesPiperacillin, Tazobactam Drug CombinationCephalosporins

Autor:innen und Institutionen

  • Department of Hematology, Uwajima City Hospital, Ehime, 798-8510, Japan. Electronic address: kaneko@uwajima-mh.jp.
  • Department of Hematology, Uwajima City Hospital, Ehime, 798-8510, Japan.
  • Clinical Laboratory Department, Uwajima City Hospital, Ehime, 798-8510, Japan.
  • Department of Hepato-Biliary-Pancreatic Surgery, Uwajima City Hospital, Ehime, 798-8510, Japan.
  • Department of Pharmacy, Uwajima City Hospital, Ehime, 798-8510, Japan.
  • Department of Infection Control and Prevention, Uwajima City Hospital, Ehime, 798-8510, Japan.

Zitieren

APA

Kaneko, M., Masuda, Y., Sawachika, H., Shikata, H., Moriyama, C., Miura, M., Yamamoto, H., Nakamura, T., Fukumoto, K., Utsunomiya, Y., Sakai, K., Ito, Y., Ujike, A., Asano, Y., & Shinomiya, H. (2023). Isolation of OXA-48-like carbapenemase-producing Escherichia coli susceptible to piperacillin/tazobactam in a Japanese patient without a history of travel abroad. Journal of Infection and Chemotherapy. https://doi.org/10.1016/j.jiac.2023.01.024

Vancouver

Kaneko M, Masuda Y, Sawachika H, Shikata H, Moriyama C, Miura M, et al. Isolation of OXA-48-like carbapenemase-producing Escherichia coli susceptible to piperacillin/tazobactam in a Japanese patient without a history of travel abroad. Journal of Infection and Chemotherapy. 2023. doi:10.1016/j.jiac.2023.01.024

BibTeX
@article{Kaneko2023,
  author = {Kaneko, Masahiko and Masuda, Yuya and Sawachika, Hiroshi and Shikata, Hisaharu and Moriyama, Chie and Miura, Minako and Yamamoto, Hisato and Nakamura, Taro and Fukumoto, Komami and Utsunomiya, Yasushi and Sakai, Kyoko and Ito, Yuri and Ujike, Ayako and Asano, Yukiko and Shinomiya, Hiroto},
  title = {Isolation of OXA-48-like carbapenemase-producing Escherichia coli susceptible to piperacillin/tazobactam in a Japanese patient without a history of travel abroad},
  journal = {Journal of Infection and Chemotherapy},
  year = {2023},
  doi = {10.1016/j.jiac.2023.01.024}
}
Kostenlos starten →